Synteract Inks Buy of Harrison Clinical

Synteract, which is backed by Gryphon Investors, has agreed to buy Harrison Clinical Research. Financial terms were not announced. Munich, Germany-based Harrison is a clinical research company.

PEHUB Community

Join the 12506 members of peHUB to make connections, share your opinion, and follow your favorite authors.

Join the Community

Look Who’s Tweeting

PE HUB News Briefs

RSS Feed Widget

VCJ Headlines (subscribers only)

RSS Feed Widget

Buyouts Headlines (subscribers only)

RSS Feed Widget

Reuters VC and PE feed

RSS Feed Widget